NRXPW vs XYL · rev $242.0K vs P/E 27, rev $4.46B
NRx Pharmaceuticals Inc (NRXPW) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
NRx Pharmaceuticals Inc (NRXPW) common stock listed on NASDAQ.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported NRXPW revenue for 2025-09-30 was $242.0K. Net income was -$5.9M. NRXPW currently screens at market cap $714.6M.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
NRXPW currently screens at market cap $714.6M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the NRXPW and XYL stock pages for the full models.
Not investment advice.